Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $11.13 USD
Change Today +0.89 / 8.69%
Volume 131.9K
DRNA On Other Exchanges
As of 8:10 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

John J. Rossi Ph.D.

Co-Founder and Chairman of Scientific Advisory Board,Dicerna Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 88 board members in 7 different organizations across 11 different industries.

See Board Relationships


Prof. John J. Rossi, Ph.D., is an Adjunct Professor, Division of Biomedical Sciences, University of California, Riverside, CA, as well as an Adjunct Professor, Department of Biochemistry and Microbiology, Loma Linda University, CA. Mr. Rossi is Co-Editor in chief of Nucleic Acid Therapeutics and Deputy Editor of Molecular Therapy. He also is an editor for JBC, Silence, BMC Biotechnology and Human Gene Therapy. His present focus is on enhancing the intracellular efficacy ...

Read Full Background

Corporate Headquarters*

87 Cambridgepark Drive
Cambridge, Massachusetts 02140

United States

Phone: 617-621-8097
Fax: 617-612-6298

Board Members Memberships*

There is no Board Members Memberships data available.


University of Connecticut
Post-Doctoral Training
Brown University
The University of New Hampshire, Durham

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DRNA:US $11.13 USD +0.89


Ali Mortazavi Chief Executive (leave of absence) and Director
Silence Therapeutics plc
200.0K GBP
J. Michael French Chairman, Chief Executive Officer and President
Marina Biotech, Inc.
Peter French B.Sc, M.Sc, Ph.D., MBAChief Executive Officer, Managing Director and Director
Benitec Biopharma Limited
Mark W. Schwartz Ph.D.Chief Executive Officer, President, Director and Member of Ad Hoc (Strategy, Pricing, Etc) Committee
Galena Biopharma, Inc.
Mark Joseph Murray Ph.D.Chief Executive Officer, President and Director
Arbutus Biopharma Corporation
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DICERNA PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at